BioScrip, Inc. (BIOS): Price and Financial Metrics
BIOS Stock Summary
- Price to trailing twelve month operating cash flow for BIOS is currently 172.78, higher than 98.19% of US stocks with positive operating cash flow.
- BIOS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 92.56% of US stocks.
- Over the past twelve months, BIOS has reported earnings growth of -213.32%, putting it ahead of just 6.88% of US stocks in our set.
- Stocks that are quantitatively similar to BIOS, based on their financial statements, market capitalization, and price volatility, are LEJU, CALM, UBOH, BANR, and GHM.
BIOS Stock Price Chart More Charts
BIOS Price/Volume Stats
|Current price||$4.18||52-week high||$4.51|
|Prev. close||$4.35||52-week low||$1.56|
|Day high||$4.39||Avg. volume||1,171,419|
|50-day MA||$3.66||Dividend yield||N/A|
|200-day MA||$3.03||Market Cap||2.95B|
BioScrip, Inc. (BIOS) Company Bio
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management services in the United States. It operates in two segments, Infusion Services and PBM Services. The company was founded in 1993 and is based in Eden Prairie, Minnesota.